🇦🇺 You're Invited: Clinical Trials - The Australian Advantage | Miami, Florida 📍 K&L Gates LLP, Miami, FL 33131, USA If you're exploring where to run your next early-phase clinical […]
Join Resolian at the 10th Impurities Summit.
Join Resolian at EIP - European Immunogenicity Platform.
🇦🇺 You're Invited: Exploring New Models of Global Clinical Trial Collaboration | Berlin, Germany 📍 Berlin Business Partner, Berlin, Germany If you're exploring where to run your next early-phase clinical […]
Join Resolian at SOT - Society of Toxicology - Annual Meeting and ToxExpo.
Join Resolian at WRIB - Workshops on Recent Issues in Bioanalysis.
DIA China Shanghai, China May 2026 Join Resolian at DIA China.
Resolian is exhibiting at Joint Pharmaceutical Analysis Group. The Chromatographic (Analytical) Method Life Cycle (2026): From Cradle to Grave III / ChromSoc Spring Symposium Join us.
Resolian are exhibiting at Formulation and Delivery Europe 2026.
Join Resolian at BIO International Convention.
Join Resolian at The ISSX 27th North American Meeting.
Join Resolian at AusBiotech.
Join Resolian at ACT - American College of Toxicology.
Join Resolian at EBF - European Bioanalysis Forum
Resolian is exhibiting at DDL 2026 Drug Delivery to the Lungs. The Annual forum for developing medicines for inhalation Resolian are at Stand 212 Join us.
Chief Scientific Officer
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Chief Executive Officer
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.